Global Over the Counter (OTC) Drugs Market Analysis By Drug Category (Cold and Cough Remedies, Vitamins and Supplements, Digestive and Intestinal Remedies, Skin Treatment, Analgesics, Sleeping Aids, Others), By Formulation Type (Tablets, Liquids, Ointments, Sprays), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: May 2025
- Report ID: 148525
- Number of Pages: 384
- Format:
-
keyboard_arrow_up
-
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunities
- 2.2.4. Key Over the Counter (OTC) Drugs Market Trends
- 2.3. Regulatory Framework
- 2.4. Opportunity Map Analysis
- 2.5. Opportunity Orbits
- 2.6. PESTLE Analysis
- 2.7. PORTER’S Five Force Analysis
- 2.8. Drivers & Restraints Impact Analysis
- 2.9. Value Chain Analysis
- 2.9.1. List of Raw Materials Suppliers
- 2.9.2. List of Over the Counter (OTC) Drugs Manufacturers
- 2.9.3. List of Dealer/Distributors
- 2.10. Regional Market Share and BPS Analysis
- 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Over the Counter (OTC) Drugs Market Analysis and Forecast, By Segment, 2020-2034
- 3.1. Key Findings
- 3.2. Global Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Category, 2020-2034
- 3.3. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- 3.3.1. Cold and Cough Remedies
- 3.3.1.1. Insights
- 3.3.1.2. Key Takeaways
- 3.3.2. Vitamins and Supplements
- 3.3.2.1. Insights
- 3.3.2.2. Key Takeaways
- 3.3.3. Digestive and Intestinal Remedies
- 3.3.3.1. Insights
- 3.3.3.2. Key Takeaways
- 3.3.4. Skin Treatment
- 3.3.4.1. Insights
- 3.3.4.2. Key Takeaways
- 3.3.5. Analgesics
- 3.3.5.1. Insights
- 3.3.5.2. Key Takeaways
- 3.3.6. Sleeping Aids
- 3.3.6.1. Insights
- 3.3.6.2. Key Takeaways
- 3.3.7. Others
- 3.3.7.1. Insights
- 3.3.7.2. Key Takeaways
- 3.3.1. Cold and Cough Remedies
- 3.4. Global Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 3.5. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- 3.5.1. Tablets
- 3.5.1.1. Insights
- 3.5.1.2. Key Takeaways
- 3.5.2. Liquids
- 3.5.2.1. Insights
- 3.5.2.2. Key Takeaways
- 3.5.3. Ointments
- 3.5.3.1. Insights
- 3.5.3.2. Key Takeaways
- 3.5.4. Sprays
- 3.5.4.1. Insights
- 3.5.4.2. Key Takeaways
- 3.5.1. Tablets
- 3.6. Global Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
- 3.7. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- 3.7.1. Hospital Pharmacies
- 3.7.1.1. Insights
- 3.7.1.2. Key Takeaways
- 3.7.2. Retail Pharmacies
- 3.7.2.1. Insights
- 3.7.2.2. Key Takeaways
- 3.7.3. Online Retailers
- 3.7.3.1. Insights
- 3.7.3.2. Key Takeaways
- 3.7.1. Hospital Pharmacies
- 4. Global Over the Counter (OTC) Drugs Market Analysis and Forecast, By Region, 2020-2034
- 4.1. Key Findings
- 4.2. Global Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
- 4.2.1. North America
- 4.2.1.1. Regional Insights
- 4.2.2. Europe
- 4.2.2.1. Regional Insights
- 4.2.3. Asia Pacific
- 4.2.3.1. Regional Insights
- 4.2.4. Latin America
- 4.2.4.1. Regional Insights
- 4.2.5. Middle East & Africa
- 4.2.5.1. Regional Insights
- 4.2.1. North America
- 4.3. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Region
- 5. North America Over the Counter (OTC) Drugs Market Analysis and Forecast, 2020-2034
- 5.1. Key Findings
- 5.2. North America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Category, 2020-2034
- 5.3. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- 5.4. North America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 5.5. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- 5.6. North America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
- 5.7. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- 5.8. North America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 5.9. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- 5.9.1. The US
- 5.9.2. Canada
- 6. Europe Over the Counter (OTC) Drugs Market Analysis and Forecast, 2020-2034
- 6.1. Key Findings
- 6.2. Europe Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Category, 2020-2034
- 6.3. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- 6.4. Europe Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 6.5. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- 6.6. Europe Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
- 6.7. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- 6.8. Europe Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 6.9. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- 6.9.1. Germany
- 6.9.2. The UK
- 6.9.3. France
- 6.9.4. Spain
- 6.9.5. Italy
- 6.9.6. Russia
- 6.9.7. Netherland
- 6.9.8. Rest of Europe
- 7. Asia Pacific Over the Counter (OTC) Drugs Market Analysis and Forecast, 2020-2034
- 7.1. Key Findings
- 7.2. Asia Pacific Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Category, 2020-2034
- 7.3. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- 7.4. Asia Pacific Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 7.5. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- 7.6. Asia Pacific Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
- 7.7. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- 7.8. Asia Pacific Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 7.9. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- 7.9.1. China
- 7.9.2. Japan
- 7.9.3. South Korea
- 7.9.4. India
- 7.9.5. Australia
- 7.9.6. New Zealand
- 7.9.7. Singapore
- 7.9.8. Thailand
- 7.9.9. Vietnam
- 7.9.10. Rest of Asia Pacific
- 8. Latin America Over the Counter (OTC) Drugs Market Analysis and Forecast, 2020-2034
- 8.1. Key Findings
- 8.2. Latin America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Category, 2020-2034
- 8.3. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- 8.4. Latin America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 8.5. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- 8.6. Latin America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
- 8.7. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- 8.8. Latin America Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 8.9. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- 8.9.1. Brazil
- 8.9.2. Mexico
- 8.9.3. Rest of Latin America
- 9. Middle East & Africa Over the Counter (OTC) Drugs Market Analysis and Forecast, 2020-2034
- 9.1. Key Findings
- 9.2. Middle East & Africa Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Category, 2020-2034
- 9.3. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- 9.4. Middle East & Africa Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 9.5. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- 9.6. Middle East & Africa Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
- 9.7. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- 9.8. Middle East & Africa Over the Counter (OTC) Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 9.9. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- 9.9.1. South Africa
- 9.9.2. Saudi Arabia
- 9.9.3. UAE
- 9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
- 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
- 10.7.1. Abbott
- 10.7.1.1. Company Details
- 10.7.1.2. Business Overview
- 10.7.1.3. Product Portfolio
- 10.7.1.4. Financial Insights
- 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.1.6. SWOT Analysis
- 10.7.1.7. Geographic Footprint
- 10.7.2. Alkem Laboratories
- 10.7.2.1. Company Details
- 10.7.2.2. Business Overview
- 10.7.2.3. Product Portfolio
- 10.7.2.4. Financial Insights
- 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.2.6. SWOT Analysis
- 10.7.2.7. Geographic Footprint
- 10.7.3. Aytu Biopharma
- 10.7.3.1. Company Details
- 10.7.3.2. Business Overview
- 10.7.3.3. Product Portfolio
- 10.7.3.4. Financial Insights
- 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.3.6. SWOT Analysis
- 10.7.3.7. Geographic Footprint
- 10.7.4. Bayer AG
- 10.7.4.1. Company Details
- 10.7.4.2. Business Overview
- 10.7.4.3. Product Portfolio
- 10.7.4.4. Financial Insights
- 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.4.6. SWOT Analysis
- 10.7.4.7. Geographic Footprint
- 10.7.5. Cipla
- 10.7.5.1. Company Details
- 10.7.5.2. Business Overview
- 10.7.5.3. Product Portfolio
- 10.7.5.4. Financial Insights
- 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.5.6. SWOT Analysis
- 10.7.5.7. Geographic Footprint
- 10.7.6. GlaxoSmithKline
- 10.7.6.1. Company Details
- 10.7.6.2. Business Overview
- 10.7.6.3. Product Portfolio
- 10.7.6.4. Financial Insights
- 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.6.6. SWOT Analysis
- 10.7.6.7. Geographic Footprint
- 10.7.7. Johnson & Johnson Services
- 10.7.7.1. Company Details
- 10.7.7.2. Business Overview
- 10.7.7.3. Product Portfolio
- 10.7.7.4. Financial Insights
- 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.7.6. SWOT Analysis
- 10.7.7.7. Geographic Footprint
- 10.7.8. Pfizer
- 10.7.8.1. Company Details
- 10.7.8.2. Business Overview
- 10.7.8.3. Product Portfolio
- 10.7.8.4. Financial Insights
- 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.8.6. SWOT Analysis
- 10.7.8.7. Geographic Footprint
- 10.7.9. Piramal Enterprises
- 10.7.9.1. Company Details
- 10.7.9.2. Business Overview
- 10.7.9.3. Product Portfolio
- 10.7.9.4. Financial Insights
- 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.9.6. SWOT Analysis
- 10.7.9.7. Geographic Footprint
- 10.7.10. Reckitt Benckiser Group
- 10.7.10.1. Company Details
- 10.7.10.2. Business Overview
- 10.7.10.3. Product Portfolio
- 10.7.10.4. Financial Insights
- 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.10.6. SWOT Analysis
- 10.7.10.7. Geographic Footprint
- 10.7.11. Sanofi
- 10.7.11.1. Company Details
- 10.7.11.2. Business Overview
- 10.7.11.3. Product Portfolio
- 10.7.11.4. Financial Insights
- 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.11.6. SWOT Analysis
- 10.7.11.7. Geographic Footprint
- 10.7.12. Sun Pharmaceuticals
- 10.7.12.1. Company Details
- 10.7.12.2. Business Overview
- 10.7.12.3. Product Portfolio
- 10.7.12.4. Financial Insights
- 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.12.6. SWOT Analysis
- 10.7.12.7. Geographic Footprint
- 10.7.13. Teva Pharmaceutical Industries
- 10.7.13.1. Company Details
- 10.7.13.2. Business Overview
- 10.7.13.3. Product Portfolio
- 10.7.13.4. Financial Insights
- 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.13.6. SWOT Analysis
- 10.7.13.7. Geographic Footprint
- 10.7.1. Abbott
- 10.1. Market Competition Scenario Analysis, By Company
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
- List of Tables
- Table 1. Global Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 2. Global Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 3. Global Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 4. Global Over the Counter (OTC) Drugs Market Value (US$ Mn), By Region, 2020-2034
- Table 5. North America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 6. North America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 7. North America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 8. North America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Country, 2020-2034
- Table 9. The US Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 10. The US Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 11. The US Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 12. Canada Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 13. Canada Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 14. Canada Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 15. Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 16. Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 17. Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 18. Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Country, 2020-2034
- Table 19. Germany Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 20. Germany Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 21. Germany Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 22. The UK Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 23. The UK Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 24. The UK Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 25. France Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 26. France Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 27. France Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 28. Spain Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 29. Spain Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 30. Spain Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 31. Italy Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 32. Italy Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 33. Italy Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 34. Russia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 35. Russia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 36. Russia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 37. Netherland Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 38. Netherland Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 39. Netherland Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 40. Rest of Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 41. Rest of Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 42. Rest of Europe Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 43. Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 44. Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 45. Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 46. Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Country, 2020-2034
- Table 47. China Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 48. China Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 49. China Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 50. India Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 51. India Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 52. India Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 53. Japan Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 54. Japan Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 55. Japan Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 56. South Korea Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 57. South Korea Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 58. South Korea Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 59. Australia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 60. Australia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 61. Australia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 62. New Zealand Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 63. New Zealand Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 64. New Zealand Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 65. Singapore Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 66. Singapore Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 67. Singapore Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 68. Thailand Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 69. Thailand Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 70. Thailand Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 71. Vietnam Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 72. Vietnam Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 73. Vietnam Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 74. Rest of Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 75. Rest of Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 76. Rest of Asia Pacific Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 77. Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 78. Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 79. Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 80. Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Country, 2020-2034
- Table 81. Brazil Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 82. Brazil Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 83. Brazil Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 84. Mexico Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 85. Mexico Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 86. Mexico Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 87. Rest of Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 88. Rest of Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 89. Rest of Latin America Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 90. Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 91. Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 92. Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 93. Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Country, 2020-2034
- Table 94. South Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 95. South Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 96. South Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 97. Saudi Arabia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 98. Saudi Arabia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 99. Saudi Arabia Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 100. UAE Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 101. UAE Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 102. UAE Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 103. Rest of Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Drug Category, 2020-2034
- Table 104. Rest of Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Application, 2020-2034
- Table 105. Rest of Middle East & Africa Over the Counter (OTC) Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
- List of Figures
- Figure 1. Global Over the Counter (OTC) Drugs Market Snapshot: Market Value (US$ Mn), 2020-2034
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Over the Counter (OTC) Drugs Market
- Figure 5. Global Over the Counter (OTC) Drugs Market Analysis, By Drug Category, 2020, 2024 and 2034
- Figure 6. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- Figure 7. Global Over the Counter (OTC) Drugs Market Analysis, By Application, 2020, 2024 and 2034
- Figure 8. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- Figure 9. Global Over the Counter (OTC) Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 10. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 11. Global Over the Counter (OTC) Drugs Market Analysis, By Region, 2020, 2024 and 2034
- Figure 12. Global Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Region
- Figure 13. North America Over the Counter (OTC) Drugs Market Analysis, By Drug Category, 2020, 2024 and 2034
- Figure 14. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- Figure 15. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Cold and Cough Remedies, 2020-2034
- Figure 16. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Vitamins and Supplements, 2020-2034
- Figure 17. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Digestive and Intestinal Remedies, 2020-2034
- Figure 18. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Skin Treatment, 2020-2034
- Figure 19. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Analgesics, 2020-2034
- Figure 20. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Sleeping Aids, 2020-2034
- Figure 21. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Others, 2020-2034
- Figure 22. North America Over the Counter (OTC) Drugs Market Analysis, By Application, 2020, 2024 and 2034
- Figure 23. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- Figure 24. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Tablets, 2020-2034
- Figure 25. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Liquids, 2020-2034
- Figure 26. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Ointments, 2020-2034
- Figure 27. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Sprays, 2020-2034
- Figure 28. North America Over the Counter (OTC) Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 29. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 30. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
- Figure 31. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
- Figure 32. North America Over the Counter (OTC) Drugs Market (US$ Mn), by Online Retailers, 2020-2034
- Figure 33. North America Over the Counter (OTC) Drugs Market Analysis, By Country, 2020, 2024 and 2034
- Figure 34. North America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- Figure 35. Europe Over the Counter (OTC) Drugs Market Analysis, By Drug Category, 2020, 2024 and 2034
- Figure 36. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- Figure 37. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Cold and Cough Remedies, 2020-2034
- Figure 38. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Vitamins and Supplements, 2020-2034
- Figure 39. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Digestive and Intestinal Remedies, 2020-2034
- Figure 40. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Skin Treatment, 2020-2034
- Figure 41. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Analgesics, 2020-2034
- Figure 42. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Sleeping Aids, 2020-2034
- Figure 43. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Others, 2020-2034
- Figure 44. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Product Type 9, 2020-2034
- Figure 45. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Cold and Cough Remedies0, 2020-2034
- Figure 46. Europe Over the Counter (OTC) Drugs Market Analysis, By Application, 2020, 2024 and 2034
- Figure 47. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- Figure 48. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Tablets, 2020-2034
- Figure 49. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Liquids, 2020-2034
- Figure 50. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Ointments, 2020-2034
- Figure 51. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Sprays, 2020-2034
- Figure 52. Europe Over the Counter (OTC) Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 53. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 54. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
- Figure 55. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
- Figure 56. Europe Over the Counter (OTC) Drugs Market (US$ Mn), by Online Retailers, 2020-2034
- Figure 57. Europe Over the Counter (OTC) Drugs Market Analysis, By Country, 2020, 2024 and 2034
- Figure 58. Europe Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- Figure 59. Asia Pacific Over the Counter (OTC) Drugs Market Analysis, By Drug Category, 2020, 2024 and 2034
- Figure 60. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- Figure 61. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Cold and Cough Remedies, 2020-2034
- Figure 62. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Vitamins and Supplements, 2020-2034
- Figure 63. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Digestive and Intestinal Remedies, 2020-2034
- Figure 64. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Skin Treatment, 2020-2034
- Figure 65. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Analgesics, 2020-2034
- Figure 66. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Sleeping Aids, 2020-2034
- Figure 67. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Others, 2020-2034
- Figure 68. Asia Pacific Over the Counter (OTC) Drugs Market Analysis, By Application, 2020, 2024 and 2034
- Figure 69. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- Figure 70. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Tablets, 2020-2034
- Figure 71. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Liquids, 2020-2034
- Figure 72. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Ointments, 2020-2034
- Figure 73. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Sprays, 2020-2034
- Figure 74. Asia Pacific Over the Counter (OTC) Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 75. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 76. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
- Figure 77. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
- Figure 78. Asia Pacific Over the Counter (OTC) Drugs Market (US$ Mn), by Online Retailers, 2020-2034
- Figure 79. Asia Pacific Over the Counter (OTC) Drugs Market Analysis, By Country, 2020, 2024 and 2034
- Figure 80. Asia Pacific Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- Figure 81. Latin America Over the Counter (OTC) Drugs Market Analysis, By Drug Category, 2020, 2024 and 2034
- Figure 82. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- Figure 83. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Cold and Cough Remedies, 2020-2034
- Figure 84. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Vitamins and Supplements, 2020-2034
- Figure 85. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Digestive and Intestinal Remedies, 2020-2034
- Figure 86. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Skin Treatment, 2020-2034
- Figure 87. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Analgesics, 2020-2034
- Figure 88. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Sleeping Aids, 2020-2034
- Figure 89. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Others, 2020-2034
- Figure 90. Latin America Over the Counter (OTC) Drugs Market Analysis, By Application, 2020, 2024 and 2034
- Figure 91. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- Figure 92. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Tablets, 2020-2034
- Figure 93. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Liquids, 2020-2034
- Figure 94. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Ointments, 2020-2034
- Figure 95. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Sprays, 2020-2034
- Figure 96. Latin America Over the Counter (OTC) Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 97. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 98. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
- Figure 99. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
- Figure 100. Latin America Over the Counter (OTC) Drugs Market (US$ Mn), by Online Retailers, 2020-2034
- Figure 101. Latin America Over the Counter (OTC) Drugs Market Analysis, By Country, 2020, 2024 and 2034
- Figure 102. Latin America Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- Figure 103. Middle East & Africa Over the Counter (OTC) Drugs Market Analysis, By Drug Category, 2020, 2024 and 2034
- Figure 104. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Drug Category
- Figure 105. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Cold and Cough Remedies, 2020-2034
- Figure 106. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Vitamins and Supplements, 2020-2034
- Figure 107. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Digestive and Intestinal Remedies, 2020-2034
- Figure 108. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Skin Treatment, 2020-2034
- Figure 109. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Analgesics, 2020-2034
- Figure 110. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Sleeping Aids, 2020-2034
- Figure 111. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Others, 2020-2034
- Figure 112. Middle East & Africa Over the Counter (OTC) Drugs Market Analysis, By Application, 2020, 2024 and 2034
- Figure 113. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Application
- Figure 114. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Tablets, 2020-2034
- Figure 115. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Liquids, 2020-2034
- Figure 116. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Ointments, 2020-2034
- Figure 117. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Sprays, 2020-2034
- Figure 118. Middle East & Africa Over the Counter (OTC) Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 119. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 120. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
- Figure 121. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
- Figure 122. Middle East & Africa Over the Counter (OTC) Drugs Market (US$ Mn), by Online Retailers, 2020-2034
- Figure 123. Middle East & Africa Over the Counter (OTC) Drugs Market Analysis, By Country, 2020, 2024 and 2034
- Figure 124. Middle East & Africa Over the Counter (OTC) Drugs Market Attractiveness Analysis, By Country
- 1. Executive Summary
-
- Abbott Laboratories
- Alkem Laboratories
- Aytu Biopharma
- Bayer AG Company Profile
- Cipla Limited Company Profile
- GlaxoSmithKline
- Johnson & Johnson Services
- Pfizer Inc Company Profile
- Piramal Enterprises Ltd Company Profile
- Reckitt Benckiser Group PLC Company Profile
- Sanofi Company Profile
- Sun Pharmaceuticals
- Teva Pharmaceutical Industries Ltd. Company Profile
- settingsSettings
Our Clients
- 148525
- May 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
